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Foreword
Tuberculosis (TB) remains to be one of the most serious health and development problems in the
WHO South-East Asia and Western Pacific Regions, which together carry more than half of the
global tuberculosis burden. Every year millions of people are newly infected with the TB bacillus,
and thousands die of the disease in these two most populous regions of the world. The spread of
the human immunodeficiency virus (HIV) during the last two decades and the emergence of
multidrug-resistant forms of TB pose additional challenges to effective TB control.
This year is a landmark for TB control. Five years ago, the World Health Assembly resolved
to achieve the global targets of 70% case detection and 85% cure rate among all new infectious
cases of TB by 2005. In addition, the Millennium Development Goals have set a new benchmark
for further reversing the trends of TB and other major communicable diseases.
Member States are accelerating their efforts to meet these goals. DOTS, the internationally
recommended strategy to control tuberculosis, is proving to be successful in many countries. We
are happy to note that nearly 90% of people in our regions have access to care under this highly
effective strategy. Over 2.2 million cases are managed under DOTS in the two regions each year.
Of these, 85% are being successfully treated, averting over 320 000 deaths.
The growing number of patients cured of this debilitating and often fatal disease reflects the
success of our interventions. This progress is largely an outcome of the sustained commitment on
the part of governments, health workers and civil society.
This publication is the first bi-regional report on tuberculosis control in the South-East Asia
and the Western Pacific Regions. It presents data on TB epidemiology and gauges the enormous
progress being made by national TB control programmes in both the regions. It presents the
overall success with strategies adopted to control TB and highlights the similarities and differences
between individual countries.
This progress needs to be sustained and built upon to enable individual countries and the
two regions to achieve the targets set under the Millennium Development Goals. This requires
continued commitment and adequate support of national TB control programmes for several
years to come.
Shigeru Omi, M.D., Ph.D. Samlee Plianbangchang, M.D., Dr.P.H.
Regional Director Regional Director
WHO Western Pacific Region WHO South-East Asia Region
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Executive Summary
This is the first bi-regional report on TB control for the WHO South-East Asia and Western Pacific
Regions. It includes data on the estimates of disease burden, case notifications and treatment
outcomes reported from 47 countries in the two regions of WHO in 2003.
Tuberculosis is still a major public health problem in both the regions. In 2003, there were
an estimated 9.7 million prevalent cases of TB (291 per 100 000 population) in the South-East
Asia and Western Pacific Regions, of which almost 5 million were new cases (149 per 100 000
population). Six countries account for about 90% of the total estimated new cases in the two
regions. China and India accounted for 63% of incident TB cases (all forms) in the two regions.
The global HIV epidemic has had an impact in countries in Asia and the Pacific: the prevalence
of HIV among TB cases was 12% in Cambodia and Thailand, 6.8% in Myanmar and 4% in Viet
Nam. In addition, drug resistance was found in almost all settings surveyed in the South-East Asia
and Western Pacific Regions; the prevalence of MDR-TB varied widely across settings ranging
from 0.5% to 10.4%. The highest prevalence rates of MDR-TB in previously untreated cases were
observed in Liaoning (10.4%) and Henan (7.8%) provinces in China.
The case-detection rate in the two regions (see Annex 1 for definition) was 51% for all
tuberculosis cases and 50% for new smear-positive cases. In other words, the 2.5 million notified
cases (all types) represented 51% of the 5 million estimated cases (all types) and the 1.1 million
notified new smear-positive cases represented 50% of the estimated new smear-positive cases.
Case detection rates in DOTS areas have been steadily increasing in the South-East Asia
Region since 1998 whereas progress in the Western Pacific Region was relatively slow until 2002.
The rise in case detection in the South-East Asia Region is largely due to significant increments in
the numbers of cases detected in India (+52%), particularly between 2002 and 2003. Similarly,
the increase in case detection in the Western Pacific Region from 2002 to 2003 (+28%) is mostly
due to a dramatic increase in case detection in China (+59%). Progress in these two countries
with the highest burdens of tuberculosis globally will necessarily drive global progress in TB
control.
In DOTS areas, the treatment cure and success rates were 82% and 88% respectively for the
cohort of 790 916 new pulmonary smear-positive cases registered for treatment in 2002 (85%
and 81% respectively in the South-East Asia Region; 91% and 84%, respectively in the Western
Pacific Region). In total, 23 countries out of 45 reported treatment outcomes below the 85%
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WHO target (five in the South-East Asia Region, including three high burden countries1 (Bangladesh,
Myanmar and Thailand) and 18 in Western Pacific Region, including two high burden countries2
(Lao PDR and Papua New Guinea).
Several challenges need to be overcome to sustain the momentum towards reaching the
global TB control targets set for end-2005. With DOTS expanding rapidly, ensuring high quality
DOTS implementation has become an important concern. Also, TB associated with HIV co-
infection and multidrug-resistant TB need to be addressed by implementing collaborative TB-
HIV activities and expanding DOTS-plus programmes designed to treat those with drug-resistant
forms of TB.
Given that tuberculosis has implications not only on health but also on the social and economic
development the achievement of several other targets under MDGs will also depend on good TB
control. This makes it all the more imperative that commitment and resources are sustained to
ensure that well-managed DOTS programmes continue to effectively reach out to all those affected
by TB.
1 Countries with a high burden of tuberculosis in the South-East Asia Region belong to the global list of 22 high burden
countries: Bangladesh, India, Indonesia, Myanmar and Thailand.
2 Seven countries in the Western Pacific Region are considered to have a high burden of tuberculosis: Cambodia, China,
Lao PDR, Mongolia, Papua New Guinea, the Philippines, Viet Nam.
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 Introduction
The WHO South-East Asia and Western Pacific Regions cover a vast geographic area with over
60% of the world’s population in 48 countries and areas. Of these 47 reported data on TB to
WHO in 2003.
During 2004, a standard form for reporting surveillance data was sent to all 48 countries
and areas in both regions. Information was collected about the number and types of TB cases
notified in 2003, on the outcomes of treatment among smear-positive and smear-negative as
well as retreatment smear-positive cases registered in 2002, and about policies and practices in
use for TB control. Also, data from drug resistance and TB-HIV surveillance were compiled.
Tuberculosis was declared a “global emergency” by WHO over a decade ago not only
because of its toll on the health of individuals but also because of its wider social and economic
impact on overall development. Targets were established to measure progress with implementation
of the DOTS strategy to combat tuberculosis by 2005. These targets include 100% population
coverage with DOTS, 70% case detection and 85% treatment success rate. Achieving these targets
is an important intermediate step towards reaching the UN Millennium Development Goal (MDG)
of halting and starting to reverse the incidence of TB by 2015. Since 2000, the WHO South-East
Asia and Western Pacific Regions have achieved significant progress. A total of 45 of 48 countries
in the regions are implementing DOTS, with the coverage reaching 84% at the end of 2003 (77%
in the South-East Asia Region and 90% in the Western Pacific Region). The two regions have
already achieved the treatment success rate target in DOTS areas and are now moving rapidly to
achieve the 70% case-detection target.
Every year, the WHO Regional Offices for South-East Asia and the Western Pacific have
separately published an annual TB report to share current knowledge on the state of the TB
epidemic in each region. This bi-regional report is the first combined report on tuberculosis in
the two regions. Its primary aim is to present data on TB epidemiology and related information
reported from national TB control programmes (NTPs) to WHO in the two regions. It highlights
the similarities and contrasts between the countries in the two regions and the overall strategies
that have been adopted to address TB.
1
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Epidemiology
This report is based on case notifications for 2003 and treatment outcomes for patients registered
in 2002 reported by national TB control programmes to the World Health Organization in 2004,
using standard data collection forms, with common definitions and variables (Annexes).
2.1 Estimated burden
Estimates of TB prevalence, incidence and mortality in countries are based on a consultative and
analytical process that takes into account all available information on case notifications; prevalence
of infection and disease; tuberculin surveys; duration of illness; proportion of smear-positive
cases; numbers of cases treated and remaining untreated; HIV prevalence and incidence; mortality
and demography. The estimates of disease burden are revised annually by WHO to reflect new
information gathered through surveillance and from special studies such as prevalence and annual
risk of tuberculosis infection (ARTI) studies conducted in countries. For instance, a national sample
survey for ARTI, recently completed in India3, was used in these calculations. The estimates are
also applied to previous years, retrospectively, when necessary. The estimated figures are WHO
provisional estimates published in the WHO Report 2005–Global Tuberculosis Control. The
methodology used for case estimates was that described in detail in the “Global Burden of
Tuberculosis”4, published in 1999, and “The Growing Burden of Tuberculosis”5, published in
2003. Methods used to study the tuberculosis epidemic are also described in “Tuberculosis:
Epidemiology and Control”6.
In all measurements of TB indicators, population estimates provided by the UN Population
Division7, are used, recognizing that these sometimes differ from population data in the countries
themselves (many of which are based on more recent survey data).
In 2003, there were an estimated 9.7 million prevalent cases of TB (291 per 100 000
population) in the South-East Asia and Western Pacific Regions, of which almost 5 million were
2
3 National Tuberculosis Institute, DGHS, India, Annual Risk of Tuberculosis Infection in Different Zones of India: A
national sample survey 2000-2003.
4 Dye C, Scheele S, Dalin P et al. Global Burden of Tuberculosis. Estimated Incidence, Prevalence, and Mortality by
Country. JAMA 1999; 282: 677–686.
5 Corbett EL, Watt CJ, Walker N et al. The Growing Burden of Tuberculosis. Global Trends and Interactions With the HIV
Epidemic. Arch Int Med 2003; 163(9): 1009-1021.
6 Kumaresan, J. Epidemiology in Tuberculosis: Epidemiology and Control (Jai P. Narain, ed), World Health Organization,
Regional Office for South East Asia, 2002 (SEA/TB/248)
7 http://esa.un.org/unpp/, accessed January 2005.
4
Tuberculosis Control in South-East Asia and Western Pacific Regions
new cases (149 per 100 000 population). China and India accounted for 63% of all incident TB
cases (all forms) in the two Regions.
It was estimated that 944 073 deaths from tuberculosis occurred in both regions in 2003
(617 211 and 326 862 in the South-East Asia and Western Pacific Regions, respectively), i.e. 28
deaths from tuberculosis per 100 000 population (38 and 19 in the South-East Asia and Western
Pacific Regions, respectively). The death rate from tuberculosis per 100 000 population was
highest in Timor-Leste (96) and Cambodia (95) as compared to 33 in India and 18 in China.
Table 1 shows the rates of change in the estimated prevalence and death rates from 1990 to
2003.
The estimated prevalence and death rates decreased in both regions at an overall yearly
rate –3% and –2%, respectively in South-East Asia and the Western Pacific.
2.2 Case Notification
Notifications
The population coverage with DOTS was 77% in the South-East Asia Region and 90% in the
Western Pacific Region in 2003, with a combined coverage of 84% in the two Regions8.
The two regions together detected 58% of the total number of cases detected globally, 23%
in the Western Pacific and 35% in South-East Asia. These two regions account for approximately
2.5 million cases of all forms of tuberculosis notified (1.5 million in South-East Asia and almost
1 million in the Western Pacific) and about 1.1 million notified cases of smear-positive tuberculosis
(672 878 in the South-East Asia Region and 454 732 in the Western Pacific Region) in 2003.
The largest number was from India with over 1 million cases (433 271 smear-positive cases)
and China with 615 868 cases (267 414 smear-positive cases). Together, these two countries
alone accounted for 40% of all reported tuberculosis cases and 37% of all smear-positive cases
reported globally.
Table 1: Estimated prevalence rates (all cases) and death rates per 100 000
from TB in the South-East Asia and Western Pacific Regions
 1990 2003 Overall change (%) 
Yearly rate of 
change (%) 
Prevalence     
South-East Asia 570 351 -38 -4 
Western Pacific 341 236 -31 -3 
Total 446 291 -35 -3 
Deaths     
South-East Asia 50 38 -24 -2 
Western Pacific 26 19 -27 -2 
Total 37 28 -24 -2 
 
8 Population coverage at the end of 2004 in excess of 90% in both regions (unpublished data from NTP annual reports
2004)
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Of all TB case notifications, 86% of all TB cases and 92% of smear-positive tuberculosis
cases were reported from DOTS areas. These proportions were slightly higher for the Western
Pacific Region: 89% and 95%, for all and smear-positive cases respectively, compared to the
South-East Asia Region where these were 85% and 91% respectively.
Notification rates
The combined case notification rate per 100 000 population in the South-East Asia and Western
Pacific Regions was 76 for 2003 (Table 2). In South-East Asia the notification rates were higher
than for the Western Pacific with a total case rate of 96 (42 per 100 000 for smear-positive)
compared to 57 in the Western Pacific (26 per 100 000 for smear-positive).
The notification rate for all cases in both regions has been steady since 1995 with the South-
East Asia Region having a higher rate (range: 86 and 102 per 100 000) than the Western Pacific
Table 2: Notification rates and other indicators for the South-East Asia and
Western Pacific Regions, 2003 (per 100 000 population)
  
South-East 
Asia 
Western 
Pacific 
Total 
Population (thousands)  1 614 648 1 732 104 3 346 752 
Case Notifications 
Overall a 1 555 385 987 927 2 543 312 All TB cases (number) 
DOTS 1 314 983 879 827 2 194 810 
Overall   96 57   76 All TB cases (rate) 
DOTS   81 51   78 
New TB cases 
Overall  672 878 454 732 1 127 610 Number smear positive(SS+) 
DOTS  610 079 431 396 1 041 475 
Overall   42 26   34 Rate (new SS+) 
DOTS   38 25   37 
Smear negative or unknown   636 706 376 679 1 013 385 
Extra pulmonary   180 865 70 506  251 371 
Re-treatment cases 
Relapse   64 936 85 982  150 918 
Treatment after failure   14 649 998  15 647 
Treatment after default   64 217 1 208  65 425 
Other retreatment   42 288 67 709  109 997 
Other   10 428 7 008  17 436 
Detection Rate 
All cases detection rate (%)    51 51   51 
New SS+ detection rate (%)    49 52   50 
Pop coverage (%)    77 90   84 
DOTS Detection Rate (%)    45 50   47 
Non-DOTS all cases   240 402 108 100  348 502 
Non-DOTS SS+   62 799 23 336  86 135 
 Includes both DOTS and Non-DOTS
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Region (range: 47 and 57 per 100 000). After a slight but steady decline since 1996, the Western
Pacific Region has experienced a more rapid increase in the notification rate from 47 to 57 per
100 000 between 2002 and 2003. The South-East Asia Region has shown a slow decline in
notification rates, followed by a slow increase since 2001, from 90 to 94 per 100 000. (Figure 1)
Case-notification rates for smear-positive cases however, have been rising steadily in the
South-East Asia Region since 1998, from 25 to 42 per 100 000, after being steady between 1995
and 1998 at around 25 per 100 000. In contrast, the smear-positive notification rate for the
Western Pacific Region has been steady between 1997 and 2002 at 22 per 100 000. A comparative
increase in the smear-positive notification rate has been made since then to 26 per 100 000.
(Figure 2)
Age- and sex-specific notification rates
The age- and sex-specific notification rates for the two regions for 2003 (Figure 3) show that the
South-East Asia Region has higher rates for both men and women than the Western Pacific Region.
Overall the highest rates are among men aged 15 to 64 years in the South-East Asia Region. In
contrast, males in the Western Pacific Region have lower rates overall and display an upward trend
in the higher age-groups indicating a shift in the epidemiology of tuberculosis. For females, the
pattern is similar to that of males in the respective regions, albeit less dramatic than the trend seen
in males. Females in the SEA Region have higher notification rates which are however lower in the
higher age groups, compared to females in the Western Pacific Region who have lower rates
overall and a slightly increasing rate in the 45+ age groups.
2.3 TB-HIV
The HIV epidemic has reached a generalized stage at the national level in only three countries in
the two regions: Cambodia, Myanmar and Thailand. In Cambodia the prevalence of HIV infection
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Figure 1: Trends in case notification rates (all forms), 1995 - 2003
Note: SEAR, South-East Asia Region; WPR, Western Pacific Region
7
Tuberculosis Control in South-East Asia and Western Pacific Regions
0
5
10
15
20
25
30
35
40
45
1995 1996 1997 1998 1999 2000 2001 2002 2003
pe
r 1
00
 0
00
SEAR WPR TOTAL
Figure 2: Case-notification rates of smear-positive cases, 1995-2003
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Figure 3: Smear-positive notification rates, by age and sex
among those aged 15 to 49 years was estimated to be 2.6% in 2003, in Myanmar the prevalence
was 1.2% and in Thailand the prevalence was 1.5%. In addition, the epidemic is generalized in six
states of India. In other countries affected by HIV9, particularly in China, Indonesia, Nepal and
Viet Nam, the HIV epidemic is still at the concentrated stage. In China, HIV prevalence data
9http://www.who.int/GlobalAtlas/PDFFactory/HIV/index.asp, accessed February 2005
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indicate a focused, explosive spread of infections among intravenous drug users (IDUs) and no
significant spread to the non-IDU population. Although HIV/AIDS cases have been detected in
all provinces, HIV transmission is focused primarily among IDUs in certain provinces. In Viet
Nam, the prevalence is highest among IDUs (24% in 2000) but sexual transmission of HIV is
increasing among female sex workers.
Tuberculosis is the most important life-threatening opportunistic infection associated with
HIV. In Thailand, 60% of AIDS patients have had pulmonary tuberculosis. This was 80% in
Myanmar, 56% in India and 75% in Nepal10.
Table 3 shows the estimated prevalence of HIV among TB cases and incidence of TB among
HIV-positive adults in countries with a high TB/HIV burden in the two regions. The overall estimated
HIV seropositivity among new adult TB cases is 3.5% in the South-East Asia Region and 1.2% in
the Western Pacific Region. The three-fold higher proportion in South-East Asia could be attributed
primarily to the high burden in India.
Table 4 shows the proportion of estimated TB deaths (numbers and rates) among those
infected with HIV for some countries in the two regions. In the South-East Asia Region, 0.7% of
prevalent TB cases are infected with HIV, but 4% of TB deaths occur among cases with HIV (11%
in Thailand). In the Western Pacific Region, 0.2% of prevalent TB cases are infected with HIV and
3% of TB deaths occur in cases infected with HIV (1.5% in Cambodia). Surveillance of HIV in
notified TB cases is not yet routinely done in all countries with concentrated or generalized HIV
epidemics.
2.4 Drug Resistance
Multidrug-resistant tuberculosis (MDR-TB) is posing a threat to tuberculosis control in several
countries.
 Prevalence of HIV in new adult 
TB cases Percentages b 
Incident cases of TB (all forms) in 
HIV+ adults (thousands) c 
Cambodia 13 6.5 
China 0.7 5.8 
Myanmar 6.8 5.5 
Nepal 2.9 0.9 
India 5.2 54.4 
Indonesia 0.5 2.3 
Thailand 8.7 5.3 
Viet Nam 2.8 1.7 
 
Table 3: Estimated prevalence of HIV in new TB cases and estimated
incidence of TB in HIV-positive adults aged 15-49 years a
a  Detailed methodology and year 2000 estimates published in Corbett et. al. 2003. Arch Intern Med 163:1009-1021.
b Global TB Report 2005, WHO (WHO/HTM/TB/2005.349) and http://www.who.int/GlobalAtlas/PDFFactory/TB/index.asp,
accessed April 2005.
c 2002 estimates accessed April 2005: http://www.who.int/docstore/gtb/tbestimates/2002tbestimates.xls
10 Jai P. Narain (ed). AIDS in Asia: The challenge ahead. WHO Regional Office for South East Asia 2004
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In 1994, WHO, the International Union Against TB and Lung Disease (The Union) and
several partners launched the Global Project on Anti-Tuberculosis Drug Resistance Surveillance.
The Global Project methodology for surveillance of drug resistance was designed around and
continues to operate on three main principles: (1) surveillance must be based on a sample of TB
patients representative of all cases in the geographical setting under evaluation; (2) drug resistance
must be clearly distinguished according to the treatment history of the patient in order to allow
correct interpretation of resistance data; and (3) optimal laboratory performance must be attained
through participation in a quality assurance programme including the international exchange of
strains of Mycobacterium tuberculosis.
Drug resistance was present in almost all settings surveyed in the South-East Asia and Western
Pacific Regions. The prevalence of drug resistance varied widely across settings though (Table 5).
Highest prevalence rates of MDR-TB were observed in Liaoning (24.4%) and Henan (36.6%)
provinces in China.
Three DOTS-plus pilot projects designed to treat MDR-TB cases under programme conditions
were initiated in Bangladesh, India, Nepal and the Philippines in 2003.
Continuous monitoring of trends in high prevalence MDR settings is essential in order to
assess current interventions and their impact on the epidemic. To date, it is difficult to interpret
trends in high MDR prevalence settings with any certainty. No area reaching MDR prevalence of
>6.5% has dropped below that point in subsequent surveys suggesting that, when a critical
threshold of transmission has been reached within a population, it may take a considerable
amount of time to decrease the prevalence of MDR-TB. The results of improved TB control
interventions under DOTS and targeted interventions such as DOTS-plus may not be as rapidly
evident in these settings as they might in a population with a lower prevalence of resistance.
TB deaths among HIV+ 
 
Numbers (thousands) Rates (per 100 000) a 
India 22.2 2.1 
Myanmar 1.4 2.9 
Thailand 1.3 2.1 
South-East Asia 26.0  
Cambodia 2.4 17.6 
China 2.2 0.2 
Malaysia 0.1 0.3 
Papua New Guinea 0.1 2.2 
Philippines 0.2 0.3 
Viet Nam 0.4 0.5 
Western Pacific 5.5  
Total 31.5  
 
Table 4: Deaths due to TB in HIV-positive patients for countries with high TB/HIV burdens
a Rates per 100 000 general population
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New cases Previously 
treated cases 
 
Year No. INH 
Resistance
Any 
Resistance
MDR No. MDR 
South-East Asia Region 
India     
North Arcot 1999 282 12.8 23.7 2.8   
Raichur District 1999 278 12.2 21.9 2.5   
Wardha District 1999 197 10.7 19.8 0.5   
Nepal 2001 755 1.6 11 1.3 171 20.5 
Thailand 2001 1 505 5.3 14.8 0.9   
Myanmar 2003 733  30.2 4 172 20.3 
Western Pacific Region 
Australia 2001 770 5.6 9.9 1.6   
Cambodia 2001 638 4.7 10.3 0 96 3.1 
China, Hong Kong 2001 3 470 2.3 10.2 0.8 169 11.2 
China        
Henan 2001 1 222 3.3 29.8 7.8 265 36.6 
Hubei 1999 859 3.7 17.5 2.1 238 21.8 
Liaoning 1999 818 5.4 42.1 10.4 86 24.4 
Inner Mongolia 2003 806 5.0 35.0 7.3   
Zhejiang 1998 802 2.7 14.8 4.5 140 35.0 
Korea 1998 2 370 4.9 10.6 2.2 283 7.0 
Japan 1997 1 374 2.0 10.3 0.9 264 19.7 
Malaysia 1996 1 001 1.0 4.2 0 16 0.0 
Mongolia 1999 405 4.4 29.4 1   
New Zealand 2001 272 4.4 11.4 0 22 0.0 
Singapore 2001 823 1.6 5.0 0.5 126 8.0 
Viet Nam 1996 640 6.7 32.5 2.3   
 
Table 5: Anti-tuberculosis drug resistance, by country
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Progress in TB Control
3.1 DOTS Coverage
Among the 48 countries and areas in the South-East Asia and Western Pacific Regions, all but two
had at least part of their population covered by DOTS units. Figure 4 shows the DOTS population
coverage achieved between 1995 and 2003.
Much of the increase in population coverage in recent years is attributed to DOTS expansion
in India, China and Myanmar.
3.2 Case Detection
The DOTS case-detection rate in the two Regions (see Annex 1 for definition) was 78% for all
tuberculosis and 47% for new smear-positive cases (Table 6). In other words, the 2.5 million
notified cases (all forms) represented 51% of the 5 million estimated cases (all forms) and the 1.1
3
Figure 4: DOTS coverage 1997-2003 in South-East Asia and Western Pacific Regions
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million notified new smear-positive
cases represented 50% of the estimated
new smear-positive cases.
The overall case-detection rate
(DOTS and non-DOTS) was 51% for
both Regions individually and
combined. For smear-positive cases, this
was 49% in South-East Asia and 52% in
the Western Pacific Region. DOTS areas
reported 47% of all estimated new
smear-positive cases (i.e. one million new smear-positive cases) in the two Regions. Case detection
has increased 34% between 2002 and 2003 in the two regions.
DOTS case detection has made steady progress in the South-East Asia Region since 1998
whereas progress in the Western Pacific Region was slow until 2002. The increase in case detection
in the South-East Asia Region is largely due to the large increase in India (+52%) between 2002
and 2003. Similarly, the increase in case detection (+28%) in the Western Pacific Region between
2002 and 2003 is mostly due to a dramatic increase in case detection in China (+59%).
If the rate of progress from 2002 to 2003 is maintained, the global target of 70% case
detection rate may be reached in both Regions by the end of 2005 or during early 2006. In total,
over 1.1 million additional new smear-positive cases will need to be detected per year to reach
the target (760 000 in the South-East Asia Region and 437 000 in the Western Pacific Region).
Table 6: DOTS case detection rates of all forms
and smear-positive (SS+) cases in 2003
DOTS case-detection rate 
(percentages) 
 
SS(+) cases Increase  
(2002–2003) 
South-East Asia 45 +36 
Western Pacific 50 +28 
Overall 47 +34 
Figure 5: Trends in DOTS case detection rates in South-East Asia and
Western Pacific Regions 1995-2003.
Note: The forecast lines for both the South-East Asia and Western Pacific Regions are based on the assumption that the
annual rate of increase between 2003 and 2006 would remain similar to the annual rate of increase from 2002 to
2003.
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3.3 DOTS Enrolment and Progress in Overall Case
Detection
Figure 6 shows trends in new smear-positive case detection rates in DOTS and non-DOTS areas
in both Regions during the period 1995 to 2003. In the South-East Asia Region, the DOTS case-
detection rate increased initially at the expense of the non-DOTS case-detection rates. The total
case-detection rate although increasing slightly, only made rapid gains after 1999. In the Western
Pacific Region, the total case-detection rate was stable from 1997 to 2002 although there was a
rapid DOTS expansion during this period.
3.4 Treatment Outcomes
In DOTS areas, the cure and treatment success rates were 82% and 88% respectively, for the
cohort of 790 916 new pulmonary smear-positive cases registered for treatment in 2002 (85%
and 81%, respectively in the South-East Asia Region, and 91% and 84%, respectively in the
Western Pacific Region). With the minimal difference between cure and treatment success rates
(6%), TB control programmes should not have difficulty in reaching 85% cure rates. It is notable
that the failure rates in both DOTS (2%) and non-DOTS (1%) areas are very low (Figure 7).
In total, 23 countries and areas out of the 45 that reported treatment outcomes below the
85% global target, five are in the South-East Asia Region, including three high burden countries11
(Bangladesh, Myanmar and Thailand), and 18 in the Western Pacific Region, including two high
burden countries12 – (Lao PDR and Papua New Guinea). Non-DOTS areas reported a lower
success rate for treatment completion than DOTS areas.
Figure 6: Trends in DOTS and non-DOTS case-detection rates (new smear-positive cases)
in the South-East Asia and Western Pacific Regions
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11 Countries with a high burden of tuberculosis in South-East Asia Region belong to the global list of 22 high burden
countries: Bangladesh, India, Indonesia, Myanmar and Thailand.
12 Seven countries in the Western Pacific Region are considered to have a high burden of tuberculosis: Cambodia, China,
Lao PDR, Mongolia, Papua New Guinea, the Philippines, Viet Nam.
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Figure 8 shows the distribution of unfavourable outcomes in both regions combined. Defaults
(36%) followed by deaths (29%) together account for close to two-thirds of all unfavourable
outcomes among new smear-positive TB cases registered under DOTS programmes in the Western
Pacific and South-East Asia Regions in 2002.
Figure 7: Treatment outcomes for new smear-positive cases registered in 2002
in DOTS and non-DOTS areas in South East-Asia and Western Pacific Regions
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Figure 8: Unfavourable outcomes among new smear-positive cases registered in 2002
in DOTS areas in South East Asia and Western Pacific Regions
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3.5 Treatment Results of Re-treatment Cases
Figure 9 shows treatment outcomes for re-treatment cases in the South-East Asia and Western
Pacific Regions. In 2003, the proportion of relapse cases among all smear-positive cases was
9.7% in the South-East Asia Region and 19% in the Western Pacific Region. The high proportion
of relapses among all smear-positive cases in the Western Pacific Region was mainly due to the
high proportion of relapses observed in China (26%). The high success rate among re-treatment
cases in China accounted for the overall high treatment success rate (92%) among re-treatment
cases in the Western Pacific Region. A larger proportion of deaths occurred among re-treatment
cases in the South-East Asia Region (7%) than among those in the Western Pacific Region (3%).
Thailand contributed to the large proportion of re-treatment deaths in the South East Asia Region
(17%). This is partly due to the higher HIV prevalence and an ageing population in Thailand.
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Figure 9: Treatment outcomes for re-treatment cases registered in 2002 (DOTS areas)
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Grouping of Countries
4.1 High Burden Countries
High burden countries include Bangladesh, India, Indonesia, Myanmar and Thailand in the South-
East Asia Region, and Cambodia, China, Lao PDR, Mongolia, Papua New Guinea, the Philippines
and Viet Nam in the Western Pacific Region13. All high burden countries in the South-East Asia
Region belong to the WHO list of 22 high burden countries14.
Epidemiology
In 2003, the high burden countries accounted for 96% of the South-East Asia Region’s population
and for 86% of the Western Pacific Region’s population; and for 95% of notified new cases in the
South-East Asia Region and for 91% of the notified new cases in the Western Pacific Region.
Overall case detection of new TB cases has made considerable progress in China and India
from 2002 to 2003 (+59% and +52% respectively). The estimated prevalence rates (all cases)
have decreased at a rate of –2%/yr in China and –4%/yr in India. The estimated incidence rate
(all cases) has decreased at a rate of –1%/yr in China but remained stable in India.
Figure 10 shows trends in DOTS and non-DOTS case-detection rates in China, India,
Indonesia and Viet Nam. In China and India, most of the increase in the DOTS case-detection
rate until 2002 has occurred at the expense of non-DOTS areas while early and extensive DOTS
coverage in Indonesia and Viet Nam resulted in a regular increase in overall case-detection rates.
Figure 11 shows the age distribution of cases in three of the highest burden countries in the
two regions. A contrasting age pattern emerges between India and Indonesia, where a hump of
higher notification rates is observed in the age group 15 to 64 years as opposed to China, where
the pattern resembles that of middle to high-income countries with increasing rates with age.
Figure 12 shows increasing notification rates with age, with the exception of the Philippines,
which follows a pattern similar to India and Indonesia but with much higher rates overall.
Progress in TB control
All countries with a high burden of TB are using WHO-recommended guidelines for national TB
control programmes. Drug procurement is centralized in all countries. National reference
4
13 Based on incidence rates per 100 000 population.
14 WHO. Global Tuberculosis Control 2005. Surveillance, Planning, Financing. WHO Geneva 2005.
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Figure 10: Trends in DOTS and non-DOTS case-detection rates (new smear-positive cases)
in China, India, Indonesia and Vietnam
Vietnam
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Figure 11: Age-specific smear-positive notification rates per 100 000 population
in China, India and Indonesia
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laboratories have been designated. All the countries use sputum microscopy for diagnosis and
directly observed treatment (DOT) is applied in most public health units within DOTS areas.
Treatment and smear microscopy examinations are free of charge in all public health facilities in
DOTS areas in these countries. Reporting of treatment results is based on cohort analysis in all
countries with DOTS programmes. Screening and treatment of contacts is done in some units only.
DOTS expansion made the most significant progress in the high burden countries. Figure 13
presents the progress of DOTS towards targets between 2002 and 2003.
Figure 12: Age-specific smear-positive notification rates per 100 000 population
in several high-burden countries in South-East Asia and Western Pacific Regions.
0
100
200
300
400
500
600
700
0-14 15-24 25-34 35-44 45-54 55-64 65+
N
ot
ifi
ca
tio
n 
ra
te
s 
pe
r 1
00
 0
00
 p
op
ul
at
io
n
Cambodia Philippines Bangladesh
Myanmar Vietnam Thailand
Figure 13: Progress of DOTS towards targets in high-burden countries
in South-East Asia and Western Pacific countries
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The treatment success in Thailand remains below the WHO target because of high death
rates, which are partly attributed to HIV and to a comparatively high proportion of older patients.
The performance of the TB programme in Papua New Guinea remains unsatisfactory.
Thailand has integrated TB and HIV programmes at the central and provincial levels, allowing
streamlined TB-HIV activities. India has successfully expanded DOTS employing contracted
national consultants who assist the state level NTP managers in implementing and monitoring the
programme at the field level. China has recently made progress in case detection as a result of a
strong political commitment at all levels and countrywide implementation of a public-public
partnership linking general hospitals and TB dispensaries. Multidrug-resistant TB remains at high
levels in several provinces, and there is a need to assess the magnitude of anti-TB drug resistance
nationally. Myanmar has continued to make steady progress with case detection and treatment
success along with phased expansion. Bangladesh and Indonesia are making slower advances in
case detection while maintaining high treatment success rates.
The transition to decentralized health care systems in countries such as Indonesia poses a
great challenge to maintaining a successful TB programme because of the limited management
capacity and insufficient human resources at provincial and district levels. Future actions in these
countries to improve the TB programme will focus on human resource development (HRD)
including capacity building through training of health staff, particularly for supervision and quality
assurance15.
Common issues and challenges include overstretched public health systems, the lack of
adequate infrastructure and sufficient skilled staff. HIV-TB and MDR-TB create additional challenges
in several countries with a high burden of TB. There is increasingly a need for greater involvement
of other sectors, particularly the private sectors to ensure access to quality services and for attention
to information, education and communication guidelines to improve community awareness and
utilization of services.
4.2 Low and Intermediate Burden Countries
High income countries
Epidemiology
Middle to high income countries include Australia, Brunei Darussalam; China, Hong Kong SAR;
China, Macao SAR, Japan; the Republic of Korea; Malaysia, New Zealand and Singapore. A
stagnation of notification rates (defined as a slowdown or reversal of the annual decline of the
crude notification rate) is observed in several countries and areas (Table 7). Notification rates
continue to decline in the Republic of Korea, Japan, Singapore and, to a lesser extent, in
Hong Kong SAR. However, the causes of this stagnation vary between countries. Although ageing
of the population and the epidemic appears to be a major contributing factor, depending on the
local situation, other factors such as migration and HIV, do play an important role. With the
exception of Malaysia, all countries have a high case-detection rate among all TB cases, well
above the 70% global target.
15 Tuberculosis Control in the South-East Asia Region 2004, WHO Regional Office for South-East Asia (SE-TB-272)
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In Hong Kong SAR and Singapore, stagnation is mainly due to ageing of the tuberculosis
epidemic and ageing of the population. Some risk groups seem to emerge, such as the urban
poor, and the homeless. Population movements may have some importance, such as migrant
workers in Singapore and travel in and out of mainland China into Hong Kong SAR.
In Malaysia, increasing tuberculosis notification rates in the 25-44 age group and the relatively
high case-fatality rates in this age group suggest that tuberculosis is increasing at least in part due
to the spread of HIV infection in this population (Figure 14).
Yearly rate of change 
in notification rates 
(%) 
Yearly 
rate of 
change in 
CDR (%) 
Case 
detection 
rate (%)  
1980-90 1990-2003 1990-2003 2003 
Australia -6.0 -1.7 0 84 
Brunei Darussalam -10.0 +1.3 -1 106 
China, Hong Kong SAR -2.7 -1.5 -3 103 
China, Macao SAR -13.0 +0.75 -1 97 
Japan -3.6 -3.7 -4 79 
Republic of Korea -4.2 -5.9 0 81 
Malaysia -3.3 +0.19 -1 61 
New Zealand -6.6 +0.25 0 94 
Singapore -7.8 -3.4 -3 92 
Table 7: Annual rate of change in notification and case-detection rates (all cases)
in middle to high-income countries
Figure 14: Age-specific case-notification rates per 100 000 population
in Malaysia, Republic of Korea, Singapore and Japan
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In Brunei Darussalam and Macao SAR, changes in diagnostic practices and/or notifications,
as well as ageing of the tuberculosis epidemic, appear most important, but transmission from
migrant workers seems to play a role.
The Republic of Korea shows a continuing decline. However, some stagnation due to ageing
of the epidemic may be expected within the next 20 years as the annual risk of infection has
declined to approximately 0.5% and therefore there is limited scope for further decline.
Treatment success was below the 85% target in Australia, Brunei Darussalam, Hong Kong
SAR, Japan, Korea, and Malaysia. This may be attributed partly to high death rates due to the age
structure of the cases in countries such as Australia (10% death rate), to an increasing impact of
HIV in countries such as Malaysia (8% death rate) where there is an increase in notification rates
in the 25-44 years age group, or to high transfer rates such as in the Republic of Korea (10%
transfer rate) where the information system does not easily capture treatment outcomes.
Progress in TB control
With the exception of Japan, the Republic of Korea and Australia, all middle to high-income
countries have 100% DOTS coverage. China and the Republic of Korea use an internet-based
surveillance system, which in the Republic of Korea also covers the private sector. Japan passed a
new legislation for tuberculosis control which will put emphasis on active case detection in high-
risk groups. TB-HIV collaborative activities were progressively being implemented in Malaysia.
Tuberculosis control has not been thoroughly assessed in vulnerable populations (migrants, elderly,
homeless, intravenous drug users), where barriers to TB services exist. Population movements
have some importance, such as migrant workers in Singapore and Brunei Darussalam, and travel
in and out of mainland China into Hong Kong SAR. TB notification rates in Australia are much
higher in the population of foreign origin and largely reflect notification rates in the country of
origin.
Countries with emerging economies
There are five countries in this category without a relatively high burden of TB, all in the South-
East Asia Region16. These countries include both mountainous nations of Bhutan, the Democratic
People’s Republic of Korea and Nepal, as well as Sri Lanka, and Timor-Leste.
Epidemiology
The case-notification rates for 2003 among this group of countries are very heterogeneous, ranging
from 16 per 100 000 in Bhutan to 132 per 100 000 in Timor-Leste. In DPR Korea’s the yearly
rate of change for case detection is at +89% between 1999 and 2003 reflecting a huge increase
in case detection from 2% to 96% in less than five years. The crude case-notification rate has also
increased over 25% during the same period.
The age-specific notification rates for Bhutan and Sri Lanka are the lowest in the group and
also fairly constant across the age groups. DPR Korea and Nepal have a similar trend with increasing
rates from 0-54 years followed by a strong decline in rates in the 55+ ages. The notification rates
16 Tuberculosis Control in the South-East Asia Region 2004, WHO Regional Office for South-East Asia (SE-TB-272)
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in Timor-Leste are greater than in the other countries in this group and have the highest rates in
the 45+ age groups.
Progress in TB control
Case-detection rates for smear-positive tuberculosis in these countries range from a low of 32%
in Bhutan to a high of 96% in DPR Korea. The highest population coverage (100%) in Bhutan is
offset by the lowest case-detection rate (32%) in this group of countries. Nepal also demonstrates
a similar paradox with high coverage (94%) but lower than optimal case detection (60%).
DPR Korea shows a reversal of this relationship with the highest case-detection rate (96%). The
case detection rate has remained fairly steady at a little over 70% in Sri Lanka during the same
period. Treatment success rates are consistently high, above 81% in all countries in this group.
A key challenge for expansion of DOTS implementation in this group of countries is
the insufficient capacity to ensure quality laboratory diagnostic services, especially in Bhutan,
Countries 
SS+ notification 
rate (per 
100 000) 
Overall SS+ 
case-detection 
rate 
CDR yearly rate 
of change 
1999-2003 
Notification rate 
yearly rate of 
change 
1999-2003 
Bhutan 16 32% 5.0% -6.1% 
DPR Korea 77 96% 89.4% 25.5% 
Nepal 57 60% 6.3% 0.5% 
Sri Lanka 23 83% -0.8% 4.3% 
Timor-Leste a 132 53% -11%* -5.2%* 
Table 8: Case-notification rates, case-detection rates and rate of change, 1999-2003
a rate of change is only for 2002-2003 period for Timor-Leste
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Figure 15: Age-specific notification rates, 2003
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DPR Korea and Sri Lanka. Technical and managerial capacity requires strengthening with minimum
staff turnover in Sri Lanka and Timor-Leste. For the hilly countries bordering India, namely Nepal
and Bhutan, internal and cross-border migration of the population remain a problem as does
population access to health care in remote regions.
Plans for further strengthening DOTS programmes in all these countries include building
managerial and human resource capacity at all levels, increasing community awareness, attention
to improved supervision and monitoring including quality assurance for laboratory services. In
addition, in Bhutan, DPR Korea and Timor-Leste’s plans are under way to improve infrastructure.
Annual risk of TB infection (ARTI) surveys are being planned in DPR Korea and Nepal. In addition,
the pilot DOTS Plus project has been initiated in Nepal.
Island Countries
Epidemiology
The island countries17 group includes Maldives in the South-East Asia Region and Pacific Island
Countries (PICs) in the Western Pacific Region: American Samoa, Cook Islands, Fiji,
French Polynesia, Guam, Kiribati, Northern Mariana Islands, Marshall Islands, the Federated States
of Micronesia, Nauru, New Caledonia, Niue, Palau, Pitcairn, Samoa, Solomon Islands, Tokelau,
Tonga, Tuvalu, Vanuatu and Wallis and Futuna.
Case-notification rates vary widely among island countries. Rates also fluctuate with time
due to the very small population size of most countries or areas. In the Pacific, higher rates are
consistently observed north of the equator, with the exception of Guam, as compared to countries
located south of the equator. Notification rates (all types) in Kiribati have been consistently higher
than 200 per 100 000 since 1998, and are the highest rates recorded in the Western Pacific
Region.
A great deal of uncertainty is attached to estimates of incidence and prevalence in individual
island countries and areas due to the limited amount of data and the small population size.
Several countries show a case-detection rate well over 100% as a result of poor estimates of
incidence and mopping up of prevalent cases.
The prevalence of HIV is low in all island countries and none of them has reached the
concentrated stage of the epidemic. HIV has therefore a very limited impact on the epidemiology
of TB in these countries.
Countries 
DOTS 
population 
coverage (%) 
Overall SS+ 
case-detection 
Rate (%) 
Treatment 
success (2002 
cohort) (%) 
SS+ Case 
notification rate 
(per 100 000) 
Bhutan 100 32 86 16 
DPR Korea 80 96 88 77 
Nepal 94 60 86 57 
Sri Lanka 74 83 81 23 
Timor-Leste 78 53 81 132 
Table 9: Progress with DOTS in 2003
17 The term “Island Countries” refers to both countries and areas
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There is limited data on drug resistance in the Island countries; overall estimates indicate
low rates of multidrug resistance.
Progress in TB control
With the exception of the Federated States of Micronesia and Wallis and Futuna, all island countries
have 100% DOTS coverage despite widely scattered populations where organization of tuberculosis
control is complicated.
Maldives was one of the first countries globally to achieve both cure rate and case-detection
targets in 1997 and has surpassed these since 2000.
Key challenges and constraints include weak supervisory capacity because of difficulties in
travelling between islands, as well as in organizing decentralized treatment services, and inadequate
laboratory capacity with limited capacity to implement national quality assurance programmes.
Monitoring with precision progress towards the Millennium Development Goals in island
countries will remain a challenge until better estimates of tuberculosis morbidity and mortality
can be obtained.
Future actions to improve TB control in Maldives will involve continued training of health
staff and an improved communications strategy, particularly in the treatment of latent TB as the
country moves towards elimination of TB entirely. Training efforts including training for TB
laboratory staff are pursued in Pacific Island countries. The majority of islands in PICs are situated
in remote locations and transport is infrequent and unreliable in some cases. Recognizing the
unique situation of the Pacific, the Secretariat of the Pacific Community (SPC), the Member
States and WHO endorsed a Pacific Strategic Plan to Stop TB in 2000.
16
Tuberculosis Control in South-East Asia and Western Pacific Regions
27
Tuberculosis Control in South-East Asia and Western Pacific Regions
WHO’S WORK
5.1 WHO’s Work in the Regions
WHO has continued to assist countries in both regions towards achieving the 2005 global targets
and in reducing the burden of TB.
Although there are separate regional strategic plans for South-East Asia Region (SEAR Strategic
Plan for TB Control 2002-200618) and the Western Pacific Region (WPR Strategic Plan 2000-
200519), the two regions share common broad strategies to achieve the goals of TB control. The
implementation of these strategies had been critical to achieving progress in both regions:
• Expanding DOTS has been the key strategy to curb the TB epidemic in both regions.
National TB programmes were assisted to build technical and managerial capacity to
ensure quality while continuing to expand DOTS to cover the entire population in
countries.
• Improving case detection as the major focus of activities closely following on DOTS
expansion. Countries were assisted to build and expand collaboration/partnerships with
other sectors and providers, and to improve community awareness and use of DOTS
services.
• Strengthening advocacy, communications and social mobilization activities to increase
political commitment and community participation in TB control.
• Implementing a collaborative approach to addressing the emerging challenge of TB-HIV
co-infection.
In the Western Pacific Region, there was strong support for implementing activities to address
the issue of multi-drug resistant-TB in several countries and enhancing country capacity for
surveillance and programme monitoring. In the South-East Asia Region, implementation of
operational research to identify replicable interventions to more effectively deliver DOTS in the
diverse health settings has been a priority activity.
WHO played a catalytic role in implementing these strategies in the countries through
focused technical support, capacity strengthening, effective coordination, information exchange,
5
18 Regional Strategic Plan for TB Control 2002-2006.  WHO Regional Office for South-East Asia, New Delhi (SE-TB-246).
19 Regional Strategic Plan to Stop TB in the Western Pacific Region 2000-2005. WHO Regional Office for the Western
Pacific. Manila. 2000.
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advocacy, monitoring and supervision, and strengthening partnerships and mobilizing resources
for TB control.
Providing timely and effective technical support
The regional and country offices continued to assist countries in effectively undertaking TB control
activities through sustained technical assistance, in-country missions, information exchange and
consensus building on effective strategies and policies for TB control.
Bringing technical assistance closer to the countries is one of the key approaches that have
led to good progress. Long-term professional staff have been posted in five countries of the SEA
Region (Bangladesh, India, Indonesia, Myanmar and Nepal) and six countries and areas in the
Western Pacific Region (Cambodia, China, Pacific island countries, Papua New Guinea, the
Philippines and Viet Nam). A network of national professional officers and national consultants is
providing technical assistance at the field level in all countries with a high burden of TB.
In both regions, WHO continues to provide targeted technical assistance for specific areas
and to strengthen the operationalization of regional and country strategies. In recent years, technical
assistance has been targeted at accelerating DOTS expansion and case detection, and in initiating
response to emerging issues that included TB-HIV, MDR-TB and collaboration between public
and private health providers for TB control.
Capacity strengthening
WHO is continuing to strengthen technical and management capacity for TB control in both
regions. One of the crucial areas is improving human resource capacity, which has been one of
the persistent challenges of TB control. WHO continues to support regional, intercountry and
national training courses on TB control in several areas, including surveillance and data
management, laboratory methods for the diagnosis of TB including quality assurance, TB-HIV
and drug resistance surveillance. WHO also supports fellows from countries for specific technical
and management capacity strengthening objectives, which were found useful by many countries
to promote exchange of information on lessons learnt with implementing DOTS and addressing
specific challenges. In the SEA Region, the inter-country courses on comprehensive TB control
and on leadership and strategic management for TB control programme managers have resulted
in similar training being undertaken at the national level. In the WP Region, around 25 TB staff
from different countries in the Region are supported to the International TB Course in Viet Nam
organized in collaboration with the International Union of Tuberculosis and Lung Diseases
(IUATLD).
WHO is building capacity in the countries to respond to challenges by developing regional
guidelines and plans and supporting countries to adapt these guidelines or plans to their specific
settings. WHO has published the Quality Assurance Guidelines for Smear Microscopy in the Western
Pacific Region, which had been the basis of the specific guidelines in some countries. To provide
guidance on TB-HIV response, the SEA Region developed the Regional Strategic Plan on HIV-TB
while the Western Pacific Region published the TB-HIV Framework for Collaborative Activities,
which now serves as the basis for country TB-HIV frameworks. Moreover, a training course on
operationalizing TB-HIV interventions, held in Thailand in January 2005 and the TB-HIV conference
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for the Mekong countries20 held in Viet Nam, will help improve country capacity for joint TB-HIV
activities.
With increasing emphasis on increasing good collaboration of health providers, especially
private health providers, WHO is supporting countries to initiate and expand the private and
public mix DOTS (PPMD) approach in some countries. Two countries in both regions, that is,
India and the Philippines, have implemented PPMD projects that could be considered as models
globally.
Effective coordination and information exchange
Both regions continued to coordinate information exchange and technical discussions on strategies
and policies for TB control at regional and country levels. In both regions, a number of meetings
were organized that include the regional Technical Advisory Group meeting, the meeting of
national TB programme managers (including laboratory managers in the case of WPR) and other
technical meetings, that include special meetings on surveillance and monitoring, PPMD,
TB-HIV and other technical areas, at the regional or at the country level. The technical advisory
or working group meetings and the meeting of the national TB managers provided opportunities
to review the programme, discuss issues and constraints, exchange lessons learned, and discuss
strategies and new approaches to overcome the challenges for TB control.
Sustaining political commitment for TB control has been part of the work. Both regions
have implemented advocacy activities to maintain a good level of interest in TB control in the
countries and also among donors. In 2004, WHO organized a China-WHO High Level Meeting
to Accelerate TB Control in the 12 priority provinces of China. At this meeting, high-level officials,
mostly vice-governors, affirmed their commitments to achieve the global TB control targets of
2005.
Strengthening partnerships and mobilizing resources for TB Control
Stop TB partnerships were established in 1999 in the Western Pacific Region and in 2003 in the
SEA Region. WHO plays a key role in strengthening partnerships for TB control by providing fora
at regional and country levels for discussions on several aspects of TB control among technical
partners and donors, including technical, strategy and policy development and implementation,
the effective and efficient use of financial resources.
WHO continues to work with international funding partners, including the Australian Agency
for International Development, Canadian International Agency, United States Agency for
International Development, Japan Government, World Bank and the Global Fund to close the
gap for TB control in both regions. WHO assisted several countries with a high burden of TB to
secure drug supplies from the Global Drug Facility and other donors, and for improving laboratory
facilities through different donors.
For the Global Fund, almost all countries which applied for funding support for their NTPs
were assisted to develop proposals during Round 4. Proposals from six countries in the two
regions (Bhutan, China, India, Laos, Mongolia and Nepal) amounting to a total of US $102
20 Mekong countries include Cambodia, China Yunnan Province, Laos, Thailand, Myanmar and Viet Nam.
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million over five years succeeded in getting Global Fund approvals during this round. Four years
after the Global Fund was established, proposals approved by the Global Fund in both regions
amount to a total of US $393 million over five years, substantially reducing the funding gap to
achieve the 2005 process targets of TB control.
Monitoring and evaluation
It is becoming increasingly important that countries be enabled to objectively measure and report
on progress towards reaching the goals set by both regions. The Regional Offices continued to
collect, compile, analyse and provide feedback to countries on routinely collected data on DOTS
implementation. Information routinely collected from countries and analysed is published in the
Global TB Control Report and the Bi-regional report on TB control in the Western Pacific and
South-East Asia Regions. Monitoring missions were undertaken together with key partners and
donors in most countries with a high burden of TB in 2004. These missions are useful for monitoring
programme performance and assessing country capacity for surveillance and programme
monitoring.
A regional workshop on surveillance and epidemiology was conducted in each of the two
regions. The workshops have contributed towards building capacity at the national level to compile,
analyse and effectively use routinely collected data and to plan for improved surveillance for TB.
In addition, several countries have initiated plans to better estimate incidence, prevalence and
mortality of TB at national and sub-national levels.
Operational research
Countries are being encouraged and supported in undertaking operational research projects that
are contributing towards identifying mechanisms to improve access, make services more
user-friendly and increase the involvement of other sectors, to further increase case detection
and improve treatment outcomes. Projects to increase collaboration among a broad range of
health providers are in place in Bangladesh, China, India, Indonesia, Republic of Korea, Myanmar
and the Philippines, while other countires are being assisted to initiate similar collaborative activities.
Communication for Behavioural Impact or COMBI, a new package for community information,
education and communication, was piloted and evaluated by the Revised National Tuberculosis
Control Programme (RNTCP) in India. Lessons learnt from these projects will be used to plan
similar efforts in other countries in the Region.
Tables
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New cases Previously treated 
cases   
Year No INH Any MDR No MDR 
WPR          
Australia 2001 770 5.6 9.9 1.6 – – 
Cambodia 2001 638 4.7 10.3 0 96 3.1 
China          
Hong Kong 2001 3470 2.3 10.2 0.8 169 11.2 
Henan 2001 1222 3.3 29.8 7.8 265 36.6 
Hubei 1999 859 3.7 17.5 2.1 238 21.8 
Liaoning 1999 818 5.4 42.1 10.4 86 24.4 
Inner Mongolia 2003 806 5 35 7.3 – – 
Zhejiang 1998 802 2.7 14.8 4.5 140 35 
Korea 1998 2370 4.9 10.6 2.2 283 7 
Japan 1997 1374 2 10.3 0.9 264 19.7 
Malaysia 1996 1001 1 4.2 0 16 0 
Mongolia 1999 405 4.4 29.4 1 – – 
New Zealand 2001 272 4.4 11.4 0 22 0 
Singapore 2001 823 1.6 5 0.5 126 8 
Viet Nam 1996 640 6.7 32.5 2.3 – – 
SEAR               
India          
North Arcot 1999 282 12.8 23.7 2.8 – – 
Raichur District 1999 278 12.2 21.9 2.5 – – 
Wardha District 1999 197 10.7 19.8 0.5 – – 
Nepal 2001 755 1.6 11 1.3 171 20.5 
Thailand 2001 1505 5.3 14.8 0.9 – – 
Myanmar 2003 733 – 30.2 4 172 20.3 
 
Country data for tuberculosis drug resistance
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Annex 1
Definitions21
1. Definitions of Tuberculosis Cases
A case of tuberculosis. A patient in whom tuberculosis has been bacteriologically confirmed, or
diagnosed by a clinician. Any person given treatment for tuberculosis should be recorded.
All types: The sum of new smear-positive pulmonary, relapse, new smear-negative pulmonary
and extrapulmonary cases.
 New smear-positive pulmonary tuberculosis: A patient who has never received treatment
for tuberculosis or has taken anti-tuberculosis drugs for less than 30 days and who has one of the
following:
• two or more initial sputum smear examinations positive for acid fast bacilli (AFB); or
• one sputum examination positive for AFB plus radiographic abnormalities consistent
with active pulmonary tuberculosis as determined by a clinician; or
• one sputum specimen positive for AFB and at least one sputum that is culture positive
for AFB.
New smear-negative pulmonary tuberculosis: A case of pulmonary tuberculosis that does
not meet the above definition for smear-positive tuberculosis:
Extrapulmonary tuberculosis: Tuberculosis of organs other than the lungs: e.g. pleura,
lymph nodes, abdomen, genito-urinary tract, skin, joints, bones, meninges, etc. Diagnosis should
be based on one culture-positive specimen, or histological or strong clinical evidence consistent
with active extrapulmonary tuberculosis, followed by a decision by a clinician to treat with a full
course of anti-tuberculosis chemotherapy. (A patient diagnosed with both pulmonary and
extrapulmonary tuberculosis should be classified as a case of pulmonary tuberculosis.)
Retreatment cases: Patient previously treated for tuberculosis, undergoing treatment for a
new episode of bacteriologically-positive (sputum smear or culture) tuberculosis.
Relapse: A patient previously treated for tuberculosis and declared cured or treatment
completed, who is later diagnosed with bacteriologically-positive (culture smear) tuberculosis.
Annexes
21 WHO, IUATLD, KNCV. Revised international definitions in tuberculosis control. Int J Tuberc Lung Dis 2001; 5: 213-
215.
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2. Definitions of Treatment Outcome
Cured: Initially smear-positive patient who was smear-negative in the last month of treatment,
and on at least one previous occasion.
Completed treatment: A patient who has completed treatment but who does not meet the
criteria to be classified as a cure or a failure.
Treatment success: The sum of patients who are cured and those who have completed
treatment.
Died: A patient who dies for any reason during the course of treatment.
Failure:  Smear-positive patient who remained smear-positive at five months or later during
treatment.
Defaulted: A patient who has interrupted treatment for two consecutive months or more.
Transferred out: A patient who has been transferred to another recording and reporting
unit and for whom the treatment outcome is not known.
Not evaluated: Patient who did not have the treatment outcome evaluated.
Note: In countries where culture is current practice, patients can be classified as cured or
failure on the basis of culture results.
3. Indicators to Assess Treatment Outcome
Cure rate: Proportion of cured cases out of all cases registered in a certain period (in 2002 in this
report).
Treatment success rates: The sum of the proportion of patients who were cured and patients
who completed treatment out of all cases registered in a certain period. The global target is a
85% cure rate and a greater treatment success rate.
The cure rate and treatment success rate are expressed as a percentage of registered cases.
The number of new cases registered for treatment in 2003 (reported in 2004) is compared to the
number of cases notified as smear-positive in 2002 (reported in 2003). Differences may arise
because NTPs do not compile data at the end of each calendar year, diagnoses may be incorrect,
patients are lost between diagnosis and the start of treatment, or lost records. All registered cases
should be evaluated. Data on the six standard, mutually exclusive outcomes of treatment are
compiled. These figures are reported as percentages of all registered cases, so that the possible
outcomes plus the fraction of cases not evaluated sum up to 100%. When a country states the
number of patients registered for treatment, but gives no outcomes, no result is reported rather
than zero treatment success. Although treatment outcomes are expressed as percentages, they
are referred to as rates. The six possible outcomes plus the fraction of cases not evaluated sum up
to 100%. If the number of registered cases is lower than the sum of the six outcomes or is missing,
the denominator for treatment success will be the number evaluated or the number of smear-
positive cases notified in the previous year, whichever is greater.
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4. Case-detection Rate and DOTS Detection Rate
DOTS. The recommended strategy for tuberculosis control. It comprises:
• Government commitment to ensuring sustained, comprehensive tuberculosis control
activities.
• Case detection by sputum smear microscopy among symptomatic patients self-reporting
to health services.
• Standardized short-course chemotherapy using regimens of six to eight months, for at
least all confirmed smear-positive cases. Good case management includes DOT during
the intensive phase for all new sputum smear-positive cases, the continuation phase of
rifampicin-containing regimens and the whole re-treatment regimen.
• A regular, uninterrupted drug supply of all essential anti-tuberculosis drugs.
• A standardized recording and reporting system that allows assessment of case-finding
and treatment results for each patient and of the tuberculosis control programme
performance overall.
Targets for tuberculosis control established by the World Health Assembly:
• To cure 85% of the sputum smear-positive tuberculosis cases detected.
• To detect 70% of the estimated new sputum smear-positive tuberculosis cases.
Case notifications represent only a fraction of the true number of cases in a country because
the coverage by effective NTPs may be incomplete.
The estimated case detection rate is defined as:
Case-detection rate (%) = Annual new smear-positive notifications (country)
Estimated annual new smear-positive incidence (country)
DOTS detection rate refers to case detection under DOTS:
DOTS detection rate (%) = Annual new smear-positive notifications under DOTS
Estimated annual new smear-positive incidence (country)
The case-detection rate and DOTS detection rate are identical when a country has a 100%
DOTS enrolment rate. Updated estimated incidence for 2003 used in this report was provided
by WHO.
Population with access to DOTS: The country’s population that lives in administrative
areas where DOTS services are available..
DOTS enrolment rate (%): This indicates a proportion of cases enrolled in DOTS out of
notified cases.
DOTS enrolment rate (all types) (%) = Annual notifications of all types under DOTS
Total of annual notifications of all types
DOTS enrolment rate (New S+) (%) = Annual notification of new S+ under DOTS
Total of annual notifications of new S+
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Annex 2
Formulas for Estimating Tuberculosis
Incidence, Prevalence and Deaths
Source: Corbett EL, Watt CJ, Walker N et al. The Growing Burden of Tuberculosis. Global Trends
and Interactions With the HIV Epidemic. Arch Int Med 2003; 163(9): 1009-1021.
Formulas Definitions 
1. I = T/d and I s= Ts/ds N = Population 
I = Incidence of TB (No. of new Cases of TB per year) 
2. P = tl and P s= tsls P = Prevalence of TB 
3. Is/N = λk T = TB case notifications (per year) 
D = Deaths from TB 
4. D = fl and D s= fls IRR = TB incidence rate ratio (TB incidence rate in 
Human Immunodeficiency [HIV]-Positive persons/TB 
incidence in HIV-Negative persons) 
5. I = Ia*+Ia-+In 
   or 
   I = ma+ra+Na++ma-ra-Na-+maraNa 
d = Proportion of cases notified (Case detection rate) 
t = Average duration of TB disease (Years) 
λ = Rate of infection with Mycobacterium tuberculosis 
(MTB) (Annual rate of infection per person per year) 
k = Ratio of incidence of smear-positive TB to rate of 
MTB Infection 
6. IRR = ma+ra+/ma-ra-=(Ia+/Na+)/(Ia-/Na-) t = Proportion of TB patients who die from TB 
(Case fatality rate [CFR]) 
m = Prevalence of infection with MTB 
7. Ia+/Ia = IRR(Na+/Na)/[1+(Na-/Na)(IRR-1)] r = Rate of progression to TB disease in MTB-infected 
individuals (per person per year) 
s = Sputum smear-positive TB (no subscript implies all 
forms) 
a = Adult (15-49 Years Old) 
8. Ia*  =  Ia+-Ia-Na+/Na- n = Other age groups (<15 or >49 Years Old), 
assumed HIV-uninfected 
9. Da* = Da+-f - (I+-Ia*) + = HIV positive 
- = HIV negative 
* = Attributable to HIV infection 
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Annex 3
Statistical Methods
Rates of change per year in time series were assessed by estimating the slope of the log-transformed
rates against time.
The statistical analysis was carried out using the R language22, freely downloadable from the
internet23.
22 Ross Ihaka and Robert Gentleman. R: A language for data analysis and graphics. Journal of Computational and Graphical
Statistics, 5(3):299-314, 1996.
23 http://www.r-project.org
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